Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹26,071.9
₹55,401 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,464.5
₹43,291 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,166.3
₹25,923 Cr
Pharmaceuticals & Drugs
₹1,366.9
₹16,782 Cr
Pharmaceuticals & Drugs
₹807.8
₹15,878 Cr
Pharmaceuticals & Drugs
₹765.7
₹12,052 Cr
Pharmaceuticals & Drugs
₹860.0
₹7,798 Cr
Pharmaceuticals & Drugs
₹431.7
₹3,940 Cr
Pharmaceuticals & Drugs
₹293.5
₹3,287 Cr
Pharmaceuticals & Drugs
₹858.4
₹490 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹807.8
₹7,784 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,464.5
₹5,776 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹765.7
₹4,502 Cr
Pharmaceuticals & Drugs
₹431.7
₹2,678 Cr
Pharmaceuticals & Drugs
₹860.0
₹1,969 Cr
Pharmaceuticals & Drugs
₹3,166.3
₹1,462 Cr
Pharmaceuticals & Drugs
₹293.5
₹750 Cr
Pharmaceuticals & Drugs
₹26,071.9
₹7,004 Cr
Pharmaceuticals & Drugs
₹858.4
₹364 Cr
Pharmaceuticals & Drugs
₹1,366.9
₹2,590 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,464.5
₹1,135 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹807.8
₹688 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,166.3
₹387 Cr
Pharmaceuticals & Drugs
₹765.7
₹293 Cr
Pharmaceuticals & Drugs
₹860.0
₹196 Cr
Pharmaceuticals & Drugs
₹431.7
₹191 Cr
Pharmaceuticals & Drugs
₹293.5
₹172 Cr
Pharmaceuticals & Drugs
₹26,071.9
₹1,615 Cr
Pharmaceuticals & Drugs
₹858.4
₹23 Cr
Pharmaceuticals & Drugs
₹1,366.9
₹603 Cr

You may also like the below Video Courses